ALK F1174V mutation confers sensitivity while ALK I1171 mutation confers resistance to alectinib. The importance of serial biopsy post progression

author
created [InstanceEdit:9700359] Rothfels, Karen, 2020-09-16
dbId 9700317
displayName ALK F1174V mutation confers sensitivity while ALK I1171 mutation confers resistance to alectinib. The importance of serial biopsy post progression
journal Lung Cancer
pages 70-2
pubMedIdentifier 26464158
schemaClass LiteratureReference
title ALK F1174V mutation confers sensitivity while ALK I1171 mutation confers resistance to alectinib. The importance of serial biopsy post progression
url http://www.ncbi.nlm.nih.gov/pubmed/26464158
volume 91
year 2016
Cite Us!